Anteris Technologies
Australia - ToowongMedical Devices
Focus: Anteris Technologies is a medical device company specializing in implantable bioscaffolds for cardiovascular applications, headquartered in Australia with a focused pipeline of transcatheter and surgical valve technologies.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
22+13 this month
Growing — net +13 jobs in 30d
28 jobs added vs 15 removed. Steady team buildout.
Should You Work at Anteris Technologies?
AI assessmentBest suited for early-stage device engineers and regulatory professionals seeking specialized cardiovascular experience; financial and pipeline clarity needed before committing.
Why Work Here
- Focused cardiovascular device portfolio with multiple clinical programs (DurAVR THV, TAVR variants, CardioCel) offering clear product development trajectories
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
11 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
DurAVR THV System
Stable
Growth
Lead transcatheter aortic valve replacement program with 4 active trials indicating advanced clinical development.
CardioCel
Help build intelligence for Anteris Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.